IMMUNOGEN INC (IMGN) is a publicly traded company in the Unknown sector. Across all available filings, 33 corporate insiders have executed 666 transactions totaling $143.6M, demonstrating a bearish sentiment with -$141.9M in net insider flow. The most recent transaction on Feb 12, 2024 involved a transaction of 1,327 shares valued at $0.
No significant insider buying has been recorded for IMGN in the recent period.
No significant insider selling has been recorded for IMGN in the recent period.
Based on recent SEC filings, insider sentiment for IMGN is bearish with an Insider Alignment Score of 1/100 and a net flow of -$141.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IMMUNOGEN INC (IMGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 33 insiders are actively trading IMGN stock, having executed 666 transactions in the past 90 days. The most active insider is Mark J. Enyedy (Executive), who has made 25 transactions totaling $69.5M.
Get notified when executives and directors at IMGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Vasconcelles Michael | Executive | Disposition | 1,327 | $N/A | $0 | |
| Feb 12, 2024 | Char Daniel | Executive | Disposition | 1,000 | $N/A | $0 | |
| Feb 12, 2024 | Wingrove Theresa | Executive | Disposition | 21,039 | $N/A | $0 | |
| Feb 12, 2024 | A. Arbuckle Stuart | Executive | Disposition | 5,381 | $N/A | $0 | |
| Feb 12, 2024 | Alan Goldberg Mark | Executive | Disposition | 60,720 | $N/A | $0 | |
| Feb 12, 2024 | Lentini Renee | Executive | Disposition | 14,723 | $N/A | $0 | |
| Feb 12, 2024 | Ann Coen Stacy | Executive | Disposition | 73,274 | $N/A | $0 | |
| Feb 12, 2024 | John Wallace Richard | Executive | Disposition | 10,000 | $N/A | $0 | |
| Feb 12, 2024 | J. Enyedy Mark | Executive | Disposition | 584,397 | $N/A | $0 | |
| Feb 12, 2024 | M. Thackray Helen | Executive | Disposition | 3,074 | $N/A | $0 | |
| Feb 12, 2024 | J. Mitchell Dean | Executive | Disposition | 103,000 | $N/A | $0 | |
| Feb 5, 2024 | Lentini Renee | Executive | Sale | 2,631 | $29.30 | $77.1K | 10b5-1 |
| Feb 5, 2024 | J. Enyedy Mark | Executive | Sale | 20,107 | $29.28 | $588.7K | Large10b5-1 |
| Feb 5, 2024 | Wingrove Theresa | Executive | Sale | 12,027 | $29.30 | $352.4K | 10b5-1 |
| Feb 5, 2024 | Ann Coen Stacy | Executive | Sale | 4,583 | $29.30 | $134.3K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 354 | $142.8M | 77.4% |
Exercise(M) | 215 | $36.8M | 20.0% |
Award(A) | 69 | $4.1M | 2.2% |
Purchase(P) | 15 | $854.6K | 0.5% |
Disposition(D) | 11 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insider selling pressure at IMMUNOGEN INC has increased, with 33 insiders executing 666 transactions across all time. Total sales of $142.8M significantly outpace purchases of $854.6K, resulting in a net outflow of $141.9M. However, 62% of these transactions are pre-scheduled 10b5-1 plans, often used for tax planning or diversification rather than signaling negative outlook.